Compare WLFC & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WLFC | CERT |
|---|---|---|
| Founded | 1985 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Retail: Computer Software & Peripheral Equipment |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | 1997 | 2020 |
| Metric | WLFC | CERT |
|---|---|---|
| Price | $54.74 | $8.52 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 10 |
| Target Price | ★ $160.00 | $11.67 |
| AVG Volume (30 Days) | 143.7K | ★ 1.9M |
| Earning Date | 05-05-2026 | 05-11-2026 |
| Dividend Yield | ★ 0.86% | N/A |
| EPS Growth | N/A | ★ 87.50 |
| EPS | ★ 2.39 | N/A |
| Revenue | ★ $569,223,000.00 | $418,838,000.00 |
| Revenue This Year | $2.75 | $4.18 |
| Revenue Next Year | $7.35 | $5.39 |
| P/E Ratio | $22.79 | ★ N/A |
| Revenue Growth | N/A | ★ 8.75 |
| 52 Week Low | $52.13 | $4.45 |
| 52 Week High | $244.62 | $13.88 |
| Indicator | WLFC | CERT |
|---|---|---|
| Relative Strength Index (RSI) | 30.19 | 58.69 |
| Support Level | $52.76 | $8.54 |
| Resistance Level | $60.00 | $8.89 |
| Average True Range (ATR) | 1.64 | 0.32 |
| MACD | 2.32 | 0.04 |
| Stochastic Oscillator | 27.26 | 92.54 |
Willis Lease Finance Corp, with its subsidiaries, is a lessor and servicer of commercial aircraft and aircraft engines. The company has two reportable business segments, which include Leasing and Related Operations and Spare Parts Sales. A majority of its revenue is generated from the Leasing and Related Operations segment, which involves acquiring and leasing, under operating leases, commercial aircraft, aircraft engines, and other aircraft equipment and the selective purchase and resale of commercial aircraft engines, aircraft equipment, and other related businesses. Geographically, the company derives maximum Lease rent revenue from the United States, followed by Europe, Asia-Pacific (excluding India), India, South America, Canada, Central America, and the Middle East.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.